Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC13H15N5O3 |
InChIKeyHWODCHXORCTEGU-UHFFFAOYSA-N |
CAS Registry142557-61-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 01 Sep 2014 |